Norman David Eansor - Mar 16, 2021 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role: Director
Signature: /s/ Michael Loiacono, Attorney-in-Fact
Stock symbol: MRKR
Transactions as of: Mar 16, 2021
Transactions value $: $249,988
Form type: 4
Date filed: 6/8/2023, 09:35 PM
Next filing: Jun 10, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRKR	Common Stock	Purchase	$250K	+14.3K	+588.34%	$17.50	16.7K	Mar 16, 2021	Direct	F1
transaction	MRKR	Common Stock	Gift	$0	-14.3K	-85.47%	$0.00	2.43K	Mar 25, 2021	Direct	F1, F2
transaction	MRKR	Common Stock	Gift	$0	+7.14K		$0.00	7.14K	Mar 25, 2021	By the John R. Eansor 2020 Exempt Trust	F1, F2
transaction	MRKR	Common Stock	Gift	$0	+7.14K		$0.00	7.14K	Mar 25, 2021	By the Scott Eansor 2020 Exempt Trust	F1, F2

Showing 1 to 4 of 4 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRKR	Stock Option (right to buy)	Award	$0	+8K		$0.00	8K	Jun 6, 2023	Common Stock	8K	$1.72	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a 10-1 reverse stock split which became effective on January 16, 2023.
F2	The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust.
F3	This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date.